CO 013: BIOMODULINA T: IMMUNOMODULATOR NATURAL PRODUCT OF THE LIFE´S QUALITY

J Pharm Pharmacogn Res 2(Suppl. 1): S7, 2014

Special supplement with the abstract book of LATINFARMA 2013

Oral Communication

CO 013: BIOMODULINA T: IMMUNOMODULATOR NATURAL PRODUCT OF THE LIFE´S QUALITY

Aznar García E1, Pereira Y1, Súarez Fundora S1, Batista Speranza G2, Leyva B3.

1Clinical Study and Sanitaries Register. Centro Nacional de Biopreparados. BioCen. Carretera de Beltrán Km 1 ½ Bejucal, La Habana, Cuba.
2Hosp. Oncológico GB Grassi Costia, Roma, Italia.
3Centro Iberoamericano para la Tercera Edad. MINSAP, La Habana, Cuba.
Abstract

Roundtable is will include a groups of lecture and free topics of one thematic: The role of the Biomoduline T, pharmaceuticals compositions based a natural polypeptide compound made up of specific thymus fractions and include the formulation for the parenteral administration. Others clinical application will be analyzed in oncology; experience in Oncology Hospital Roma, Quality specification and stability was defined. The non clinical and clinical assay was demonstrated effectiveness and safety in geriatrics patient, inflammatory and autoimmune diseases. Study in geriatrics patients with respiratory disease was evaluated clinical and immunological cellular test before and after the beginning of the treatment. This medication is recommended for the immunological dysfunction. The study about the effect of Biomodulin T in children present with recurrent infection and a decrease of thymic area showed that after the treatment decreases of infections and increases the thymic area. The others clinical applications are evaluated: Cancer patient with chemotherapy treatment, rheumatoid arthritis, multiple sclerosis, AIDS, and immunodeficiency atypical.